A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors
Clinical trial NCT07092748 · RECRUITING
Trial details
- NCT number
- NCT07092748
- Sponsor
- Zhejiang Hisun Pharmaceutical Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2028-06-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.